Search Results - "Walcher, Stephan"

Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal by Sarrazin, Christoph, Boesecke, Christoph, Golsabahi‐Broclawski, Solmaz, Moog, Gero, Negro, Francesco, Silaidos, Carmina, Patel, Polly, Lohmann, Kristina, Spinner, Christoph D., Walcher, Stephan, Wedemeyer, Heiner, Wörns, Marcus‐Alexander

“…Hepatitis C virus (HCV) affects over 70 million people globally, with an estimated 399 000 HCV‐related deaths in 2016. The World Health Organization (WHO) has…”
Get full text

Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone by Beck, Thilo, Haasen, Christian, Verthein, Uwe, Walcher, Stephan, Schuler, Christoph, Backmund, Markus, Ruckes, Christian, Reimer, Jens

“…Aims To compare the efficacy of slow‐release oral morphine (SROM) and methadone as maintenance medication for opioid dependence in patients previously treated…”
Get full text

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study by Litwin, Alain H., Drolet, Martine, Nwankwo, Chizoba, Torrens, Martha, Kastelic, Andrej, Walcher, Stephan, Somaini, Lorenzo, Mulvihill, Emily, Ertl, Jochen, Grebely, Jason

“…The aim of this analysis was to evaluate perceived barriers related to HCV testing, management and treatment among physicians practicing in clinics offering…”
Get full text

Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder by Maremmani, Icro, Dematteis, Maurice, Gorzelanczyk, Edward J, Mugelli, Alessandro, Walcher, Stephan, Torrens, Marta

“…Long-acting buprenorphine formulations have been recently marketed for the Opioid Agonist Treatment (OAT) of opioid use disorder (OUD) associated with medical,…”
Get full text

Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE study by Grebely, Jason, Drolet, Martine, Nwankwo, Chizoba, Torrens, Martha, Kastelic, Andrej, Walcher, Stephan, Somaini, Lorenzo, Mulvihill, Emily, Ertl, Jochen, Liebert, Ryan, Litwin, Alain H.

“…This study evaluated competency related to HCV testing, management and treatment among physicians practicing in clinics offering opioid agonist treatment…”
Get full text

High Concomitant Misuse of Fentanyl in Subjects on Opioid Maintenance Treatment by Krause, Daniela, Plörer, Diana, Koller, Gabriele, Martin, Gabi, Winter, Catja, Adam, Roland, Canolli, Minavere, Al-Iassin, Jori, Musselmann, Rainer, Walcher, Stephan, Schäfer, Frank, Pogarell, Oliver

“…Background: Concomitant opioid misuse is an increasing problem in opioid maintenance treatment as it interferes with treatment success. Objective: Therefore,…”
Get full text

The opiate dosage adequacy scale for identification of the right methadone dose--a prospective cohort study by Walcher, Stephan, Koc, John, Reichel, Volker, Schlote, Frank, Verthein, Uwe, Reimer, Jens

“…Opioid maintenance treatment with methadone is regarded as gold standard in the therapy of opioid dependence. Identification of the 'right' methadone dose,…”
Get full text

When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study by Reimer, Jens, Boniakowski, Eduard, Bachner, Christian, Weber, Bernd, Tietje, Wieland, Verthein, Uwe, Walcher, Stephan

“…Opioid replacement treatment (ORT) with methadone is regarded as gold standard in the treatment of opioid addiction. Treatment doses of 60 mg methadone per day…”
Get full text

Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine by Lehmann, Kirsten, Kuhn, Silke, Baschirotto, Cinzia, Jacobsen, Britta, Walcher, Stephan, Görne, Herbert, Backmund, Markus, Scherbaum, Norbert, Reimer, Jens, Verthein, Uwe

“…Since April 2015, slow-release oral morphine (SROM) has been approved for opioid agonist treatment (OAT) in Germany. Experimental studies show that benefits of…”
Get full text

Substance-Associated Co-Morbidity During Oral Maintenance Therapy Impacts Outcome of Hepatitis C Therapy: Conjoint Analysis of Data From Two German Noninterventional Cohorts by Weber, Bernd, Mauss, Stefan, Hey, Karl-Heinz, Michael, Waizmann, Schober, Andreas, Bellmann, Gabriele, Büscher, Karl-Georg, Link, Ralph, Mauruschat, Sabine, Cimander, Konrad F, Breske, Antje, Walcher, Stephan

Get full text